Neuronetics Inc. (NASDAQ: STIM) Stock Information | RedChip

Neuronetics Inc. (NASDAQ: STIM) Listen to this Section


$1.12
+0.1550 ( +16.06% ) 919.6K

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Market Data


Open


$1.12

Previous close


$0.97

Volume


919.6K

Market cap


$33.93M

Day range


$0.94 - $1.20

52 week range


$0.66 - $5.07

Insider Ownership Transactions

Total Amount Purchased: -31,468.00 | $ -35,244.16

Date Type Amount Purchased Purchaser
2023-10-10 Sale -1499.00 Furlong Stephen
2023-10-10 Sale -1469.00 MACAN WILLIAM ANDREW
2023-08-11 Sale -28500.00 CASCELLA ROBERT

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Mar 28, 2024
8-k 8K-related 13 Mar 25, 2024
10-k Annual reports 117 Mar 08, 2024
8-k 8K-related 14 Mar 06, 2024
8-k 8K-related 16 Mar 05, 2024
8-k 8K-related 14 Mar 05, 2024
4 Insider transactions 1 Mar 01, 2024
4 Insider transactions 1 Mar 01, 2024
4 Insider transactions 1 Feb 29, 2024
4 Insider transactions 1 Feb 28, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.